Persistent URL of this record https://hdl.handle.net/1887/3184641
Documents
-
- Download
- 1-s2.0-S1043661820313074-main
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Rimeporide as a first- in-class NHE-1 inhibitor: results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy
- All authors
- Previtali, S.C.; Gidaro, T.; Diaz-Manera, J.; Zambon, A.; Carnesecchi, S.; Roux-Lombard, P.; Spitali, P.; Signorelli, M.; Szigyarto, C.A.K.; Johansson, C.; Gray, J.; Labolle, D.; Thome, F.P.; Pitchforth, J.; Domingos, J.; Muntoni, F.
- Date
- 2020-09-01
- Journal
- Pharmacological Research
- Volume
- 159